A new vision screening device, already shown to give an early warning of eye disease, could give doctors and patients a head start on treating diabetes and its vision complications, a new study shows.

A new therapy developed at Cedars-Sinai Medical Center improves transplant rates and outcomes for patients awaiting living- and deceased-donor kidney transplantation, according to a study published in the July 17 issue of the New England Journal of Medicine.

A review of studies reveals that the newer, long-acting insulin medications offer only a slight benefit over NPH in terms of blood glucose control in type 1 diabetes. Researchers did see a clear benefit of long-acting insulin in reducing the risk for hypoglycemia, particularly at night.

New research shows that some sweeteners, especially date sugar and dark brown sugars, contain antioxidants that have the potential to control diabetes-linked heart disease and high blood pressure. Some sweeteners used in the study also had the ability to inhibit the activity of a key enzyme related to Type 2 …

The finding comes from a systematic review of 13 observational studies looking at the link between diabetes and TB over the past four decades.

Community-based health programs aimed at diet, exercise, smoking prevention and other known risk factors for chronic diseases could cut health-care costs in the United States by $16 billion a year, at a cost of 10 dollars per patient/year, a new report says.

Biodel announced that its two pivotal Phase III VIAject(TM) clinical trials are now complete. The full trial results will be released either at Biodel’s poster presentation at the European Association for the Study of Diabetes (EASD) on Tuesday, September 9, 2008, or at a later appropriate scientific forum.

Researchers at the University of Warwick have discovered diabetes could be a hidden condition for some patients with coronary heart disease.

Losing weight through diet and exercise lowers diabetes risk in men and women, but men may have to work harder for the same benefit, new research suggests.

Results of a meta-analysis indicate that the antiepileptic agent pregabalin is safe and effective for relieving pain in diabetic peripheral neuropathy (DPN).